Studies have shown that NAT10 promotes the progression of various malignant tumor diseases, such as colorectal, breast, and cervical cancer (Liu et al., 2019; Liu et al., 2020; Chen et al., 2023b; Jin et al., 2022). Here, NAT10 is linked to cervical carcinoma.